Report: Eye Infections Treatment Market Poised for Steady Growth in the Future

Source: Future Market Insights

Wednesday, March 15, 2017 | Medical Studies


The eye infections treatment market is growing. This is attributed to aging population, rising prevalence of ophthalmic diseases, increasing company investments for launching new product forms, health conscious population, free eye check-up camps funded by the government in the different regions. Secondly rising awareness regarding various eye infections and rising prevalence of blindness amongst the geriatric population driving the growth of eye infection treatment market. However stringent government regulations in various drugs development procedures and the side effects associated with various antibiotics would impede the adoption of eye infection pharmaceutical treatment, thereby, hamper the market growth.
 
Eye Infections Treatment Market: Segmentation
 
This market is segmented on the basis of product type, distribution channel and drug class
 
Segmentation based on product type:
 
Gels & Creams
Eye drops
Drug
Antibiotic
Anti-fungal
Anti-bacterial
Anti-viral
Anti-inflammatory
Lubricants
Anti-allergens
 
Segmentation based on distribution channel:
 
Ophthalmology Clinics
Hospitals
Retail Pharmacies
Online Pharmacies
 
Eye Infections Treatment Market: Overview

 
There are different OTC as well as prescription based drugs available in the market to treat eye infection including artificial tear drops, ointments, eye wash, hyper osmotic, scrub, decongestants, and antihistamines, antibacterial, antifungal, and antiviral. Some of the important and widely used drugs in ocular infections include fluoroquinolones, aminoglycosides, macrolides and others.
 
Eye Infections Treatment Market: Region-wise Outlook
 
Globally, the eye infections treatment market is expected to witness healthy growth in the near future due to increasing awareness about eye care, global aging population and the rise in per capita expenditure on healthcare in the developing nations. North America region dominate the eye infection treatment followed by Europe owing to technological advancement and more number of market players in these regions. Asia-Pacific market is expected to register fastest growth owing to the rise in geriatric population and also the rise in prevalence of blindness in geriatric population.
 
Eye Infections Treatment Market: Key Players
 
Some of the key market players in global point-of-care test market are Allergan, Alcon Laboratories, Johnson & Johnson, Pfizer, Merck & Co., Novartis, Santen Pharmaceuticals, Valeant Pharmaceuticals, Bayer, GlaxoSmithKline, Sanofi-Aventis, and Bausch & Lomb.
 
To access the full report, visit www.futuremarketinsights.com/reports/sample/rep-gb-1300
 


Comments

You must be logged in to leave a comment.